Internal Medicine, Hematology & Oncology · Wilson, NC
NPI
1730161092
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
2624 Ortho Dr
Wilson, NC, 27893
Phone (252) 991-5261
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.7M
162,795 services
Medicare patients, 2024
803
Average age 76
Drug cost, 2024
$11.1M
2,954 prescriptions
Company payments, 2025
$4,640
From 62 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Keith Lerro was code J0897 (injection, denosumab, 1 mg), 22,155 times for 152 patients. In total Keith Lerro billed 162,795 services in 124 codes, and Medicare paid $3.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-09-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 22,155 | 152 | $20.52 | $455K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 14,700 | 12 | $8.45 | $124K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 8,700 | 57 | $15.72 | $137K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,530 | 42 | $0.09 | $228 |
| 85025 Blood Count | Office | 2,281 | 470 | $7.55 | $17K |
| 36415 Venipuncture Blood Collection | Office | 1,181 | 465 | $6.87 | $8,109 |
| 99214 Office E&M - Established | Office | 1,032 | 453 | $87.20 | $90K |
| 96372 Injection Administration | Office | 858 | 222 | $9.61 | $8,248 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 850 | 18 | $0.70 | $595 |
| 99232 Hospital E&M - Subsequent | Facility | 409 | 86 | $59.00 | $24K |
| 96367 Intravenous Infusion, Hydration | Office | 325 | 45 | $20.40 | $6,629 |
| 96413 Chemotherapy Administration | Office | 312 | 42 | $91.46 | $29K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 280 | 32 | $0.89 | $250 |
| 80053 Clinical Chemistry | Office | 274 | 59 | $10.35 | $2,836 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 254 | 35 | $4.75 | $1,205 |
By year: 2022 $4.5M for 185,011 services; 2023 $4.3M for 169,225 services; 2024 $3.7M for 162,795 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,281 | 470 | $7.55 | $17K |
| 36415 Venipuncture Blood Collection | 1,181 | 465 | $6.87 | $8,109 |
| 80053 Clinical Chemistry | 274 | 59 | $10.35 | $2,836 |
| 85610 Clinical Chemistry | 227 | 11 | $4.20 | $953 |
| 81001 Clinical Chemistry | 56 | 17 | $3.11 | $174 |
Medicare prescription drug claims, 2024
In 2024, the drug Keith Lerro prescribed most often to Medicare patients was Anastrozole, with 263 prescriptions and refills. In total Keith Lerro wrote 2,954 Medicare prescriptions that cost $11.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 263 | 534 | 65 | $4,365 |
| Procrit Epoetin Alfa | 183 | 183 | 48 | $344K |
| Eliquis Apixaban | 135 | 151 | 25 | $88K |
| Prolia Denosumab | 99 | 596 | 65 | $169K |
| Xarelto Rivaroxaban | 88 | 98 | 17 | $56K |
| Warfarin Sodium Generic | 83 | 157 | 18 | $785 |
| Abiraterone Acetate Generic | 82 | 82 | Under 11 | $131K |
| Dexamethasone Generic | 71 | 83 | 20 | $1,518 |
| Udenyca Pegfilgrastim-Cbqv | 67 | 67 | 16 | $265K |
| Letrozole Generic | 65 | 105 | 15 | $2,137 |
| Potassium Chloride Generic | 64 | 75 | 28 | $551 |
| Oxycodone Hcl Generic | 62 | 62 | 27 | $1,383 |
| Fentanyl Generic | 62 | 62 | 20 | $7,303 |
| Prednisone Generic | 62 | 76 | 17 | $641 |
| Hydroxyurea Generic | 59 | 98 | 18 | $1,471 |
Brand drugs: 1,410 claims; generic drugs: 1,544 claims; opioid claims: 220.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Keith Lerro $4,640 ($4,640 in general payments such as food, travel and fees) from 62 companies. The largest payer was Dendreon Pharmaceuticals LLC with $454.
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 17 | $454 |
| Daiichi Sankyo Inc. 4568.T | 7 | $309 |
| Janssen Biotech, Inc. JNJ | 13 | $260 |
| Merck Sharp & Dohme LLC MRK | 9 | $236 |
| Abbvie Inc. ABBV | 7 | $199 |
| Pfizer Inc. PFE | 10 | $181 |
| Eisai Inc. 4523.T | 5 | $174 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $174 |
| Incyte Corporation INCY | 4 | $148 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $132 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.